These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 44374)

  • 1. Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients.
    Smith RC; Tamminga CA; Crayton JW; Dekirmenjian H; Davis JM
    Psychopharmacology (Berl); 1979; 66(1):29-33. PubMed ID: 44374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazine.
    Garver DL; Dekirmenjian H; Davis JM; Casper R; Ericksen S
    Am J Psychiatry; 1977 Mar; 134(3):304-7. PubMed ID: 14514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenothiazine levels in plasma and red blood cells. Their relationship to clinical improvement in schizophrenia.
    Casper R; Garver DL; Dekirmenjian H; Chang S; Davis JM
    Arch Gen Psychiatry; 1980 Mar; 37(3):301-5. PubMed ID: 6102458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood levels of neuroleptic drugs in nonresponding chronic schizophrenic patients.
    Smith RC; Crayton J; Dekirmenjian H; Klass D; Davis JM
    Arch Gen Psychiatry; 1979 May; 36(5):579-84. PubMed ID: 35115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of plasma prolactin to clinical response in schizophrenic patients.
    Gruen PG; Sachar EJ; Altman N; Langer G; Tabrizi MA; Halpern FS
    Arch Gen Psychiatry; 1978 Oct; 35(10):1222-7. PubMed ID: 29592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
    Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
    Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma butaperazine levels in long-term chronic non-responding schizophrenics.
    Smith RC; Dekirmenjian H; Davis JM; Crayton J; Evans H
    Commun Psychopharmacol; 1977; 1(4):319-24. PubMed ID: 28201
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions.
    Garver DL; Davis JM; Dekirmenjian H; Jones FD; Casper R; Haraszti J
    Arch Gen Psychiatry; 1976 Jul; 33(7):862-6. PubMed ID: 8025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of butaperazine in biological fluids by gas chromatography using nitrogen specific detection system.
    Javaid JI; Dekirmenjian H; Liskevych U; Davis JM
    J Chromatogr Sci; 1979 Dec; 17(12):666-70. PubMed ID: 43334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of butaperazine in serum.
    Davis JM; Janowsky DS; Sekerke HJ; Manier H; el-Yousef MK
    Adv Biochem Psychopharmacol; 1974; 9(0):433-43. PubMed ID: 4151767
    [No Abstract]   [Full Text] [Related]  

  • 11. Butaperazine pharmacokinetics. Effect of dosage regimen on steady state blood levels.
    Cooper TB; Simpson GM; Haher EF; Bergner PE
    Arch Gen Psychiatry; 1975 Jul; 32(7):903-5. PubMed ID: 239664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between blood levels of different forms of butaperazine and clinical response.
    Simpson GM; Lament R; Cooper TB; Lee JH; Bruce RB
    J Clin Pharmacol; 1973 Jul; 13(7):288-97. PubMed ID: 4145866
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolactin response to single and multiple doses of haloperidol in schizophrenic patients.
    Ravichandran GK; Lu RB; Shvartsburd A; Misra CH; Ho BT; Kahn M; Smith RC
    Psychiatry Res; 1984 Jan; 11(1):61-9. PubMed ID: 6584932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of butaperazine and plasma methionine-enkephalin levels in schizophrenic and affective disorder patients with tardive dyskinesia.
    Mosnaim AD; Wolf ME
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):27S-30S. PubMed ID: 2906066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of conjugated estrogens on plasma butaperazine levels.
    El-Yousef MK; Manier DH
    Psychopharmacologia; 1974; 39(1):39-41. PubMed ID: 4153665
    [No Abstract]   [Full Text] [Related]  

  • 16. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neuroleptics on platelet monoamine oxidase activity.
    Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
    Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of neuroleptics on serum prolactin in schizophrenic patients.
    Meltzer HY; Fang VS
    Arch Gen Psychiatry; 1976 Mar; 33(3):279-86. PubMed ID: 1259521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fluorometric method for the measurement of butaperazine in human plasma.
    Manier DH; Sekerke J; Dingell JV; El-Yousef MK
    Clin Chim Acta; 1974 Dec; 57(3):225-30. PubMed ID: 4154816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.